Regional chemotherapy for biliary tract tumors and hepatocellular carcinoma Review


Authors: Mondaca, S.; Yarmohammadi, H.; Kemeny, N. E.
Review Title: Regional chemotherapy for biliary tract tumors and hepatocellular carcinoma
Abstract: Locally advanced hepatocellular carcinoma and intrahepatic cholangiocarcinoma are associated with a grim prognosis. The development of highly effective systemic therapies for these tumors has been challenging; however, numerous locoregional treatment alternatives have emerged, including transarterial hepatic embolization (TAE), transarterial chemoembolization (TACE), drug-eluting bead TACE (DEB-TACE), hepatic arterial infusion chemotherapy (HAI), radioembolization, and stereotactic body radiation therapy. Although there is potential for long-term disease control for these therapies, the evidence to guide adequate patient selection and choose among different treatment alternatives is still limited. This review focuses on the rationale and data supporting TAE, TACE, DEB-TACE, and HAI in hepatobiliary cancers. © 2019 Elsevier Inc.
Keywords: hepatocellular carcinoma; chemoembolization; cholangiocarcinoma; hepatic arterial infusion chemotherapy
Journal Title: Surgical Oncology Clinics of North America
Volume: 28
Issue: 4
ISSN: 1055-3207
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: 717
End Page: 729
Language: English
DOI: 10.1016/j.soc.2019.06.008
PUBMED: 31472915
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Nancy Kemeny
    543 Kemeny